|
|
|
42
|
6711MK
|
APO-LEVOFLOXACIN 750MG TAB (APO)
|
LEVOFLOXACIN
|
APO-LEVOFLOXACIN
|
30'S
|
B
|
35.18
|
1.17
|
TAB
|
14
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
081218
|
QUINOLONES
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
QUINOLONES
|
|
|
|
|
42
|
6711MS
|
CIPROFLOXACIN 500MG TAB (HEA)
|
CIPROFLOXACIN
|
CIPROFLOXACIN
|
10X10
|
A
|
15.74
|
0.16
|
TAB
|
14
|
BLIS
|
HEA
|
HEALTH 2000 INC
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081218
|
QUINOLONES
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
QUINOLONES
|
2025-10-31
|
|
|
|
42
|
6711NK
|
CIPROFLOXACIN 500MG TAB (HEA)
|
CIPROFLOXACIN
|
CIPROFLOXACIN
|
10X10
|
A
|
15.74
|
0.16
|
TAB
|
14
|
BLIS
|
HEA
|
HEALTH 2000 INC
|
CWS
|
CAPSULE WHOLESALE
|
|
081218
|
QUINOLONES
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
QUINOLONES
|
2026-01-26
|
|
|
|
42
|
6711NL
|
CIPROFLOXACIN 500MG TAB (HEA)
|
CIPROFLOXACIN
|
CIPROFLOXACIN
|
10X10
|
A
|
15.74
|
0.16
|
TAB
|
14
|
|
HEA
|
HEALTH 2000 INC
|
STO
|
BRYDEN STOKES LTD
|
|
081218
|
QUINOLONES
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
QUINOLONES
|
2026-02-27
|
|
|
|
41
|
6711Q
|
CIPROXINA 500MG TAB (BSP) CIPROFLOX (C)
|
CIPROFLOXACIN
|
CIPROXINA
|
30'S
|
C
|
81.55
|
2.7183
|
TAB
|
14
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
081218
|
QUINOLONES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
QUINOLONES
|
|
|
|
|
42
|
6711Q
|
CIPROXINA 500MG TAB (BSP) CIPROFLOX
|
CIPROFLOXACIN
|
CIPROXINA
|
30'S
|
C
|
51.95
|
1.73
|
TAB
|
14
|
BLIS
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
AVENTA BARBADOS
|
|
081218
|
QUINOLONES
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
QUINOLONES
|
|
|
|
|
40
|
6711V
|
TRIZOLIN 400MG TAB (REM/SBI) NORFLOXACIN
|
NORFLOXACIN
|
TRIZOLIN
|
2X7'S
|
A
|
3.04
|
0.22
|
TABLET
|
14
|
TAB
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
081218
|
QUINOLONES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
6711V
|
TRIZOLIN 400MG TAB (REM) NORFLOXACIN
|
NORFLOXACIN
|
TRIZOLIN
|
2X7'S
|
A
|
5.41
|
0.3864
|
TAB
|
14
|
BOX
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
081218
|
QUINOLONES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
QUINOLONES
|
|
|
|
|
40
|
67123
|
CIPROXINA 200MG INJ (BSP/COL) CIPROFLOXACIN
|
CIPROFLOXACIN
|
CIPROXINA
|
100ML
|
C
|
55.73
|
55.73
|
INJECTION
|
0
|
VIAL
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
081218
|
QUINOLONES
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
67123
|
CIPROXINA 200MG INJ (BSP) CIPROFLOXACIN (C)
|
CIPROFLOXACIN
|
CIPROXINA
|
100ML
|
C
|
55.73
|
55.7256
|
VIAL
|
56
|
VIAL
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
081218
|
QUINOLONES
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
QUINOLONES
|
|
|
|
|
42
|
67123
|
CIPROXINA 200MG INJ (BSP) CIPROFLOXACIN
|
CIPROFLOXACIN
|
CIPROXINA
|
100ML
|
C
|
35.26
|
35.26
|
VIAL
|
56
|
VIAL
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
AVENTA BARBADOS
|
|
081218
|
QUINOLONES
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
QUINOLONES
|
|
|
|
|
41
|
67124
|
CIPROXINA 400MG INJ (BSP) CIPROFLOX (C)
|
CIPROFLOXACIN
|
CIPROXINA
|
200ML
|
C
|
70.68
|
70.6764
|
VIAL
|
0
|
VIAL
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
081218
|
QUINOLONES
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
QUINOLONES
|
|
|
|
|
42
|
67124
|
CIPROXINA 200MG INJ (BSP) CIPROFLOXACIN
|
CIPROFLOXACIN
|
CIPROXINA
|
200ML
|
C
|
64.32
|
64.32
|
VIAL
|
56
|
VIAL
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
AVENTA BARBADOS
|
|
081218
|
QUINOLONES
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
QUINOLONES
|
|
|
|
|
40
|
67127
|
TAVANIC 500MG INJ (SFA/COL) LEVOFLOXACIN
|
LEVOFLOXACIN
|
TAVANIC
|
100ML
|
C
|
23.11
|
23.11
|
INJECTION
|
0
|
VIAL
|
SFA
|
SANOFI AVENTIS
|
COL
|
COLLINS LTD
|
|
081218
|
QUINOLONES
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
6712BW
|
LEVOFLOXACIN 500MG INJ (BAX/STO)
|
LEVOFLOXACIN
|
LEVOFLOXACIN
|
100ML
|
BQ
|
12.07
|
12.07
|
INJECTION
|
0
|
VIAL
|
BAX
|
BAXTER EXPORT CORP.
|
STO
|
BRYDEN STOKES LTD
|
|
081218
|
QUINOLONES
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
6712BX
|
CIPLOXIN 200MG INJ (UNI/AHI) CIPROFLOXACIN
|
CIPROFLOXACIN
|
CIPLOXIN
|
100ML
|
BQ
|
4.49
|
4.49
|
INJECTION
|
0
|
VIAL
|
UNI
|
UNIQUE PHARMACEUTICAL LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081218
|
QUINOLONES
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
6712BX
|
CIPLOXIN 200MG INJ (UNI) CIPROFLOXA (BQ)
|
CIPROFLOXACIN
|
CIPLOXIN
|
100ML
|
BQ
|
4.49
|
4.4852
|
VIAL
|
56
|
VIAL
|
UNI
|
UNIQUE PHARMACEUTICAL LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081218
|
QUINOLONES
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
QUINOLONES
|
|
|
|
|
42
|
6712BX
|
CIPLOXIN 200MG INJ (UNI) CIPROFLOXA
|
CIPROFLOXACIN
|
CIPLOXIN
|
100ML
|
B
|
4.49
|
4.49
|
VIAL
|
56
|
VIAL
|
UNI
|
UNIQUE PHARMACEUTICAL LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081218
|
QUINOLONES
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
QUINOLONES
|
|
|
|
|
40
|
6712C
|
AVELOX 400MG INJ (BSP/COL) MOXIFLOXACIN
|
MOXIFLOXACIN
|
AVELOX
|
250ML
|
C
|
50.70
|
50.70
|
INJECTION
|
0
|
VIAL
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
081218
|
QUINOLONES
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
6712C
|
AVELOX 400MG INJ (BSP) MOXIFLOXACIN (C)
|
MOXIFLOXACIN
|
AVELOX
|
250ML
|
C
|
50.7
|
50.6967
|
VIAL
|
0
|
VIAL
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
081218
|
QUINOLONES
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
QUINOLONES
|
|